SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-196697
Filing Date
2018-06-19
Accepted
2018-06-19 14:15:18
Documents
10
Period of Report
2018-06-19

Document Format Files

Seq Description Document Type Size
1 6-K d591267d6k.htm 6-K 17977
2 EX-1.1 d591267dex11.htm EX-1.1 180143
3 EX-4.1 d591267dex41.htm EX-4.1 408135
4 EX-4.2 d591267dex42.htm EX-4.2 36237
5 EX-4.3 d591267dex43.htm EX-4.3 36117
6 EX-5.1 d591267dex51.htm EX-5.1 11322
7 EX-5.2 d591267dex52.htm EX-5.2 13038
8 GRAPHIC g591267g0619033954818.jpg GRAPHIC 1952
9 GRAPHIC g591267g0619034249058.jpg GRAPHIC 1952
10 GRAPHIC g591267g80i53.jpg GRAPHIC 2482
  Complete submission text file 0001193125-18-196697.txt   713371
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 18906842
SIC: 2834 Pharmaceutical Preparations